Fingerprint
Dive into the research topics of 'JAK/STAT inhibition with ruxolitinib enhances oncolytic virotherapy in non-small cell lung cancer models'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
JAK/STAT inhibition with ruxolitinib enhances oncolytic virotherapy in non-small cell lung cancer models
Manish R. Patel, Alexander Dash, Blake A. Jacobson, Yan Ji, Daniel Baumann, Kareem Ismail, Robert A. Kratzke
Research output: Contribution to journal › Article › peer-review
58
Scopus
citations